<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="other"><!--/tmp/30911.pmc.30911/meta_YMGME4354.xml--><!--LETTER TO THE EDITOR--><?origin publisher?><?FILEmeta_YMGME4354 xml ?><?FILEmain xml ?><front><journal-meta><journal-id journal-id-type="nlm-ta">Mol Genet Metab</journal-id><journal-title>Molecular Genetics and Metabolism</journal-title><issn pub-type="ppub">1096-7192</issn><issn pub-type="epub">1096-7206</issn><publisher><publisher-name>Academic Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">YMGME4354</article-id><article-id pub-id-type="doi">10.1016/j.ymgme.2008.01.008</article-id><article-categories><subj-group subj-group-type="heading"><subject>Letter to the Editor</subject></subj-group></article-categories><title-group><article-title>Gene duplications resulting in over expression of glucokinase are not a common cause of hypoglycaemia of infancy in humans</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>van de Bunt</surname><given-names>Martijn</given-names></name></contrib></contrib-group><contrib-group><contrib contrib-type="author"><name><surname>Edghill</surname><given-names>Emma L.</given-names></name></contrib></contrib-group><contrib-group><contrib contrib-type="author"><name><surname>Hussain</surname><given-names>Khalid</given-names></name></contrib></contrib-group><contrib-group><contrib contrib-type="author"><name><surname>Ellard</surname><given-names>Sian</given-names></name></contrib></contrib-group><contrib-group><contrib contrib-type="author"><name><surname>Gloyn</surname><given-names>Anna L.</given-names></name><email>anna.gloyn@drl.ox.ac.uk</email><xref rid="cor1" ref-type="corresp">&#x0204e;</xref></contrib></contrib-group><aff><addr-line>Diabetes Research Laboratories, Oxford Centre for Diabetes, Endocrinology &#x00026; Metabolism, Churchill Hospital Old Road, Headington, Oxford, UK</addr-line></aff><aff><addr-line>Institute of Biomedical &#x00026; Clinical Science, Peninsula Medical School, Exeter, UK</addr-line></aff><aff><addr-line>Institute of Child Health, Great Ormond Street Hospital, London, UK</addr-line></aff><aff><addr-line>Institute of Biomedical &#x00026; Clinical Science, Peninsula Medical School, Exeter, UK</addr-line></aff><aff><addr-line>Diabetes Research Laboratories, Oxford Centre for Diabetes, Endocrinology &#x00026; Metabolism, Churchill Hospital Old Road, Headington, Oxford, UK</addr-line></aff><author-notes><corresp id="cor1"><label>&#x0204e;</label>Corresponding author.</corresp></author-notes><pub-date pub-type="ppub"><month>6</month><year>2008</year></pub-date><volume>94</volume><issue>2</issue><fpage>268</fpage><lpage>269</lpage><history><date date-type="received"><day>18</day><month>1</month><year>2008</year></date><date date-type="accepted"><day>19</day><month>1</month><year>2008</year></date></history><permissions><copyright-statement>&#x000a9; 2008 Elsevier Inc.</copyright-statement><copyright-year>2008</copyright-year><copyright-holder>Elsevier Inc.</copyright-holder><license><p>This document may be redistributed and reused, subject to <ext-link ext-link-type="uri" xlink:href="http://www.elsevier.com/wps/find/authorsview.authors/supplementalterms1.0">certain conditions</ext-link>.</p></license></permissions></article-meta></front><body><p>It is well established that chromosome rearrangements and duplications which result in the loss of or the over expression of gene(s) can result in syndromes which feature hypoglycaemia <xref rid="bib1 bib2" ref-type="bibr">[1,2]</xref>. More recently studies have demonstrated the importance of &#x0201c;gene dosage&#x0201d; in monogenic disorders of the pancreatic &#x003b2;-cell <xref rid="bib3 bib4" ref-type="bibr">[3,4]</xref>. Investigators routinely screen for mutations using the gold standard methodology of direct sequencing of the coding regions and conserved splice sites of the gene of interest, however this method does not detect heterozygous deletions or duplications of one or more exons of the gene. <italic>Hypoglycaemia of infancy (HI)</italic> is a rare condition characterised by unregulated insulin secretion despite hypoglycaemia. Mutations in genes encoding the K<sub>ATP</sub>-channel subunits SUR1(<italic>ABCC8</italic>) and Kir6.2 (<italic>KCNJ11</italic>), glucokinase (<italic>GCK</italic>), the mitochondrial enzymes glutamate-dehydrogenase (<italic>GLUD1</italic>) and short-chain 3-hydroxyacyl-CoA-dehydrogenase (<italic>SCHAD</italic>) are responsible for approximately 50% of the cases of <italic>HI</italic><xref rid="bib5" ref-type="bibr">[5]</xref>. <italic>GCK</italic> activating mutations have been reported in a relatively small number of cases (<italic>n</italic>&#x000a0;=&#x000a0;7) of <italic>HI</italic> and are characterised by regulated insulin secretion albeit at a reduced threshold for glucose stimulated insulin release <xref rid="bib6" ref-type="bibr">[6]</xref>. The majority of patients can be treated successfully with the potassium channel opener diazoxide or with diet treatment alone, although cases that have undergone partial pancreatectomy have been reported <xref rid="bib7" ref-type="bibr">[7]</xref>.</p><p>A number of studies in rodents have shown than over expression of the glucokinase gene results in increased enzyme activity <xref rid="bib8 bib9 bib10" ref-type="bibr">[8&#x02013;10]</xref>. Over expression resulting from <italic>GCK</italic> gene duplications would result in increased liver and &#x003b2;-cell glucokinase activity and could therefore result in hypoglycaemia. We hypothesised that duplications of <italic>GCK</italic> might play a role in the pathogenesis of <italic>HI</italic> and account for the significant number of cases of <italic>HI</italic> of unknown genetic aetiology. To determine the putative role of partial or whole gene duplications of <italic>GCK</italic>, we screened the <italic>GCK</italic> gene for copy number variation using a multiplex ligation-dependent probe amplification (MLPA) assay in unrelated subjects with unexplained <italic>HI</italic> (<italic>n</italic>&#x000a0;=&#x000a0;33). The clinical characteristics of the patients screened are shown in <xref rid="tbl1" ref-type="table">Table 1</xref>. The MLPA assays were performed using a synthetic <italic>GCK</italic> probe mix as reported by Ellard et al. and the data was analysed as described by Lai et al. <xref rid="bib4 bib11" ref-type="bibr">[4,11]</xref>. No duplications of the <italic>GCK</italic> gene were detected in the 33 patients screened. Our data therefore suggest that over expression of glucokinase is unlikely to be a common cause of <italic>HI</italic> in humans but does not exclude rare cases where <italic>GCK</italic> duplications may contribute to a lowering of blood glucose levels. In conclusion, there is no evidence to support including a <italic>GCK</italic> dosage assay in the diagnostic testing repertoire for <italic>HI</italic>.</p></body><back><ack><title>Acknowledgments</title><p>The authors thank Sarah Flanagan for her technical assistance. This work was supported in Oxford by the Medical Research Council. MvdB acknowledges the support of the Dutch Diabetes Research Foundation.</p></ack><ref-list><title>References</title><ref id="bib1"><label>[1]</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>M.</given-names></name><name><surname>Squire</surname><given-names>J.A.</given-names></name><name><surname>Weksberg</surname><given-names>R.</given-names></name></person-group><article-title>Molecular genetics of Wiedemann&#x02013;Beckwith syndrome</article-title><source>Am. J. Med. Genet.</source><year>1998</year><volume>79</volume><issue>4</issue><fpage>253</fpage><lpage>259</lpage><pub-id pub-id-type="pmid">9781904</pub-id></citation></ref><ref id="bib2"><label>[2]</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bitner-Glindzicz</surname><given-names>M.</given-names></name><name><surname>Lindley</surname><given-names>K.J.</given-names></name><name><surname>Rutland</surname><given-names>P.</given-names></name><name><surname>Blaydon</surname><given-names>D.</given-names></name><name><surname>Smith</surname><given-names>V.V.</given-names></name><name><surname>Milla</surname><given-names>P.J.</given-names></name></person-group><article-title>A recessive contiguous gene deletion causing infantile hyperinsulinism, enteropathy and deafness identifies the Usher type 1C gene</article-title><source>Nat. Genet.</source><year>2000</year><volume>26</volume><issue>1</issue><fpage>56</fpage><lpage>60</lpage><pub-id pub-id-type="pmid">10973248</pub-id></citation></ref><ref id="bib3"><label>[3]</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bellanne-Chantelot</surname><given-names>C.</given-names></name><name><surname>Clauin</surname><given-names>S.</given-names></name><name><surname>Chauveau</surname><given-names>D.</given-names></name><name><surname>Collin</surname><given-names>P.</given-names></name><name><surname>Daumont</surname><given-names>M.</given-names></name><name><surname>Douillard</surname><given-names>C.</given-names></name></person-group><article-title>Large genomic rearrangements in the hepatocyte nuclear factor-1beta (TCF2) gene are the most frequent cause of maturity-onset diabetes of the young type 5</article-title><source>Diabetes</source><year>2005</year><volume>54</volume><issue>11</issue><fpage>3126</fpage><lpage>3132</lpage><pub-id pub-id-type="pmid">16249435</pub-id></citation></ref><ref id="bib4"><label>[4]</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ellard</surname><given-names>S.</given-names></name><name><surname>Thomas</surname><given-names>K.</given-names></name><name><surname>Edghill</surname><given-names>E.L.</given-names></name><name><surname>Owens</surname><given-names>M.</given-names></name><name><surname>Ambye</surname><given-names>L.</given-names></name><name><surname>Cropper</surname><given-names>J.</given-names></name></person-group><article-title>Partial and whole gene deletion mutations of the GCK and HNF1A genes in maturity-onset diabetes of the young</article-title><source>Diabetologia</source><year>2007</year><volume>50</volume><issue>11</issue><fpage>2313</fpage><lpage>2317</lpage><pub-id pub-id-type="pmid">17828387</pub-id></citation></ref><ref id="bib5"><label>[5]</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>De Leon</surname><given-names>D.D.</given-names></name><name><surname>Stanley</surname><given-names>C.A.</given-names></name></person-group><article-title>Mechanisms of disease: advances in diagnosis and treatment of hyperinsulinism in neonates</article-title><source>Nat. Clin. Pract. Endocrinol. Metab.</source><year>2007</year><volume>3</volume><issue>1</issue><fpage>57</fpage><lpage>68</lpage><pub-id pub-id-type="pmid">17179930</pub-id></citation></ref><ref id="bib6"><label>[6]</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gloyn</surname><given-names>A.L.</given-names></name></person-group><article-title>Glucokinase (GCK) mutations in hyper- and hypoglycemia: maturity-onset diabetes of the young, permanent neonatal diabetes, and hyperinsulinemia of infancy</article-title><source>Hum. Mutat.</source><year>2003</year><volume>22</volume><issue>5</issue><fpage>353</fpage><lpage>362</lpage><pub-id pub-id-type="pmid">14517946</pub-id></citation></ref><ref id="bib7"><label>[7]</label><citation citation-type="book"><person-group person-group-type="author"><name><surname>Christesen</surname><given-names>H.B.</given-names></name><name><surname>Herold</surname><given-names>K.</given-names></name><name><surname>Noordam</surname><given-names>K.</given-names></name><name><surname>Gloyn</surname><given-names>A.</given-names></name></person-group><article-title>GK linked hypoglycemia: clinical aspects of activating glucokinase mutations</article-title><person-group person-group-type="editor"><name><surname>Matschinsky</surname><given-names>F.M.M.</given-names></name></person-group><source>Glucokinase and Glycemic Diseases: From the Basics to Novel Therapeutics</source><year>2004</year><publisher-name>Karger</publisher-name><fpage>75</fpage><lpage>91</lpage></citation></ref><ref id="bib8"><label>[8]</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>O&#x02019;Doherty</surname><given-names>R.M.</given-names></name><name><surname>Lehman</surname><given-names>D.L.</given-names></name><name><surname>Telemaque-Potts</surname><given-names>S.</given-names></name><name><surname>Newgard</surname><given-names>C.B.</given-names></name></person-group><article-title>Metabolic impact of glucokinase overexpression in liver: lowering of blood glucose in fed rats is accompanied by hyperlipidemia</article-title><source>Diabetes</source><year>1999</year><volume>48</volume><issue>10</issue><fpage>2022</fpage><lpage>2027</lpage><pub-id pub-id-type="pmid">10512368</pub-id></citation></ref><ref id="bib9"><label>[9]</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Niswender</surname><given-names>K.D.</given-names></name><name><surname>Shiota</surname><given-names>M.</given-names></name><name><surname>Postic</surname><given-names>C.</given-names></name><name><surname>Cherrington</surname><given-names>A.D.</given-names></name><name><surname>Magnuson</surname><given-names>M.A.</given-names></name></person-group><article-title>Effects of increased glucokinase gene copy number on glucose homeostasis and hepatic glucose metabolism</article-title><source>J. Biol. Chem.</source><year>1997</year><volume>272</volume><issue>36</issue><fpage>22570</fpage><lpage>22575</lpage><pub-id pub-id-type="pmid">9278411</pub-id></citation></ref><ref id="bib10"><label>[10]</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ferre</surname><given-names>T.</given-names></name><name><surname>Pujol</surname><given-names>A.</given-names></name><name><surname>Riu</surname><given-names>E.</given-names></name><name><surname>Bosch</surname><given-names>F.</given-names></name><name><surname>Valera</surname><given-names>A.</given-names></name></person-group><article-title>Correction of diabetic alterations by glucokinase</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>1996</year><volume>93</volume><issue>14</issue><fpage>7225</fpage><lpage>7230</lpage><pub-id pub-id-type="pmid">8692973</pub-id></citation></ref><ref id="bib11"><label>[11]</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lai</surname><given-names>K.K.</given-names></name><name><surname>Lo</surname><given-names>I.F.</given-names></name><name><surname>Tong</surname><given-names>T.M.</given-names></name><name><surname>Cheng</surname><given-names>L.Y.</given-names></name><name><surname>Lam</surname><given-names>S.T.</given-names></name></person-group><article-title>Detecting exon deletions and duplications of the DMD gene using multiplex ligation-dependent probe amplification (MLPA)</article-title><source>Clin. Biochem.</source><year>2006</year><volume>39</volume><issue>4</issue><fpage>367</fpage><lpage>372</lpage><pub-id pub-id-type="pmid">16413013</pub-id></citation></ref></ref-list></back><floats-wrap><table-wrap position="float" id="tbl1"><label>Table 1</label><caption><p>Clinical Characteristics of subjects studied</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Variable</th><th/></tr></thead><tbody><tr><td><italic>n</italic></td><td>33</td></tr><tr><td>% Male</td><td>48.5</td></tr><tr><td>Age at diagnosis (days)</td><td>139.1 (336.5)</td></tr><tr><td><xref rid="tblfn1" ref-type="table-fn">&#x02217;</xref>Age at examination (yrs)</td><td>6.1 (5.8)</td></tr><tr><td>Fasting glucose (mmol/L)</td><td>2.02 (0.57)</td></tr><tr><td>Current treatment (%) (diazoxide/pancreatectomy/octreotide/diet/not known)</td><td>45/36/6/3/9</td></tr><tr><td>Birth weight (g)</td><td>3361.7 (823.3)</td></tr><tr><td>% With birth weight over 70th percentile</td><td>51</td></tr></tbody></table><table-wrap-foot><fn><p>Data are mean (SEM).</p></fn></table-wrap-foot><table-wrap-foot><fn id="tblfn1"><label>&#x02217;</label><p>Fasting glucose measurement.</p></fn></table-wrap-foot></table-wrap></floats-wrap></article> 